Clinical Trials Directory

Trials / Completed

CompletedNCT00000314

M-CPP and Fenfluramine in Cocaine Addicts - 3

To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
Male
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.

Conditions

Interventions

TypeNameDescription
DRUGM-CPP

Timeline

Start date
1994-09-01
Primary completion
1999-08-01
Completion
1999-08-01
First posted
1999-09-21
Last updated
2017-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000314. Inclusion in this directory is not an endorsement.